Charles & Colvard Ltd. [NASDAQ: CTHR] closed the trading session at $0.88 on 09/18/20. The day’s price range saw the stock hit a low of $0.8218, while the highest price level was $0.948. The company report on September 14, 2020 that Charles & Colvard Launches Caydia(TM), an Exclusive Brand of Lab Grown Diamonds.
– Company expands gem and fine jewelry offerings to include premium lab created diamonds -.
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / September 14, 2020 / Charles & Colvard, Ltd. (NASDAQ:CTHR) (the “Company”), a globally recognized lab created gemstone company specializing in fine jewelry, today announced the launch of Caydia, an exclusive brand of premium lab grown diamonds. Charles & Colvard is the original source of created moissanite, and debuted its premium moissanite gemstone brand Forever OneTM, in 2015. As an e-commerce and multichannel destination for fine jewelry featuring lab grown gems, Charles & Colvard believes that the addition of lab grown diamonds is a natural progression for the Company.
The stocks have a year to date performance of -37.87 percent and weekly performance of 29.28 percent. The stock has been moved at 37.96 percent over the last six months. The stock has performed 26.81 percent around the most recent 30 days and changed 25.17 percent over the most recent 3-months.
If compared to the average trading volume of 298.80K shares, CTHR reached to a volume of 1233119 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Charles & Colvard Ltd. [CTHR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CTHR shares is $1.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CTHR stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Merriman Curhan Ford have made an estimate for Charles & Colvard Ltd. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 04, 2008. While these analysts kept the previous recommendation, Northland Securities dropped their target price from $4 to $2. The new note on the price target was released on February 22, 2008, representing the official price target for Charles & Colvard Ltd. stock. Previously, the target price had yet another drop from $7 to $4, while Northland Securities kept a Market Perform rating on CTHR stock.
The Average True Range (ATR) for Charles & Colvard Ltd. is set at 0.06, with the Price to Sales ratio for CTHR stock in the period of the last 12 months amounting to 0.82. The Price to Book ratio for the last quarter was 0.61, with the Price to Cash per share for the same quarter was set at 0.51.
CTHR stock trade performance evaluation
Charles & Colvard Ltd. [CTHR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 29.28. With this latest performance, CTHR shares gained by 26.81% in over the last four-week period, additionally plugging by 37.96% over the last 6 months – not to mention a drop of -36.07% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CTHR stock in for the last two-week period is set at 81.26, with the RSI for the last a single of trading hit 88.30, and the three-weeks RSI is set at 74.07 for Charles & Colvard Ltd. [CTHR]. The present Moving Average for the last 50 days of trading for this stock 0.7130, while it was recorded at 0.8019 for the last single week of trading, and 0.8938 for the last 200 days.
Charles & Colvard Ltd. [CTHR]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Charles & Colvard Ltd. [CTHR] shares currently have an operating margin of -21.64 and a Gross Margin at +27.37. Charles & Colvard Ltd.’s Net Margin is presently recorded at -21.11.
Return on Total Capital for CTHR is now -14.20, given the latest momentum, and Return on Invested Capital for the company is -13.98. Return on Equity for this stock declined to -14.14, with Return on Assets sitting at -12.32. When it comes to the capital structure of this company, Charles & Colvard Ltd. [CTHR] has a Total Debt to Total Equity ratio set at 4.32. Additionally, CTHR Total Debt to Total Capital is recorded at 4.14, with Total Debt to Total Assets ending up at 3.66. Long-Term Debt to Equity for the company is recorded at 2.35, with the Long-Term Debt to Total Capital now at 2.26.
Reflecting on the efficiency of the workforce at the company, Charles & Colvard Ltd. [CTHR] managed to generate an average of -$128,377 per employee. Receivables Turnover for the company is 22.17 with a Total Asset Turnover recorded at a value of 0.58.Charles & Colvard Ltd.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.50 and a Current Ratio set at 3.70.
Earnings per share (EPS) analysis for Charles & Colvard Ltd. [CTHR] stock
With the latest financial reports released by the company, Charles & Colvard Ltd. posted 0.01/share EPS, while the average EPS was predicted by analysts to be reported at 0/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CTHR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Charles & Colvard Ltd. go to 30.00%.
Charles & Colvard Ltd. [CTHR]: Insider Ownership positions
There are presently around $4 million, or 21.10% of CTHR stock, in the hands of institutional investors. The top three institutional holders of CTHR stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 1,165,168, which is approximately 66.269% of the company’s market cap and around 1.40% of the total institutional ownership; VANGUARD GROUP INC, holding 775,772 shares of the stock with an approximate value of $0.68 million in CTHR stocks shares; and ARISTIDES CAPITAL LLC, currently with $0.59 million in CTHR stock with ownership of nearly -56.748% of the company’s market capitalization.
Positions in Charles & Colvard Ltd. stocks held by institutional investors increased at the end of September and at the time of the September reporting period, where 12 institutional holders increased their position in Charles & Colvard Ltd. [NASDAQ:CTHR] by around 861,148 shares. Additionally, 15 investors decreased positions by around 2,961,168 shares, while 9 investors held positions by with 567,841 shares. The mentioned changes placed institutional holdings at 4,390,157 shares, according to the latest SEC report filing. CTHR stock had 7 new institutional investments in for a total of 386,842 shares, while 8 institutional investors sold positions of 578,355 shares during the same period.